77 results
F-1
SPRC
SciSparc Ltd
27 Feb 24
Registration statement (foreign)
4:15pm
company.
Our principal executive offices, most of our research and development activities and other significant operations are located in Israel … substantially if and as we:
continue the research and development of our product candidates;
expand the scope of our current clinical studies for our product
F-3/A
SPRC
SciSparc Ltd
20 Nov 23
Shelf registration (foreign) (amended)
4:22pm
a complete loss of your investment.
Our principal executive offices, most of our research and development activities and other significant … headquarters and principal research and development facilities are located in Israel. In addition, all of our officers and directors are residents of Israel
F-3
SPRC
SciSparc Ltd
3 Nov 23
Shelf registration (foreign)
4:06pm
offices, most of our research and development activities and other significant operations are located in Israel, and, therefore, our results may … from the Gaza Strip and Israel’s war against them.
Our executive offices, corporate headquarters and principal research and development facilities
6-K
EX-99.1
SPRC
SciSparc Ltd
18 Oct 23
Report of Foreign Private Issuer
6:54am
objectives, plans, and strategies ; the expected timing of trials ; its product pipeline ; the research, development, and use of its platform … , Israel. Adi Zuloff - Shani, PhD CTO Dr. Zuloff - Shani is a Research & Development professional with overall experience of about 20 years in the bio
6-K
EX-99.1
oal55vzbr thpq2g1d89
16 Oct 23
Interim Consolidated Financial Statements
5:00pm
6-K
EX-99.2
jr7cp5izhtn
16 Oct 23
Interim Consolidated Financial Statements
5:00pm
6-K
ecv zhdfxf
14 Aug 23
SciSparc Ltd. Announces Pricing of $1.3 Million Underwritten Public Offering
4:31pm
424B5
0bw0hao
14 Aug 23
Prospectus supplement for primary offering
9:14am
424B3
hp0yao
10 Aug 23
Prospectus supplement
6:32am
424B5
p0u27n
16 May 23
Prospectus supplement for primary offering
5:30pm
6-K
sqzx7teviyslf3e
29 Dec 22
Interim Consolidated Financial Statements
4:03pm
6-K
EX-99.1
wh34tgni9c8q6p7
29 Dec 22
Interim Consolidated Financial Statements
4:03pm
6-K
EX-99.2
ih035
29 Dec 22
Interim Consolidated Financial Statements
4:03pm
6-K
EX-99.3
3c9duj48fz74dcwq2ntu
30 Sep 22
SciSparc Enters Agreement to Acquire Wellution™, Top Seller of American Food Supplements and Cosmetics Brand on Amazon, for $20 million
7:27am
F-3
k7k rvchs9yc708r8
7 Jul 22
Shelf registration (foreign)
4:22pm
POS AM
7s8trcsq2jonq
28 Apr 22
Prospectus update (post-effective amendment)
5:20pm
6-K
EX-99.1
tcqrmzeu 7yy6t
10 Mar 22
SciSparc Launches New JV Targeting Discovery of Potential Drugs for Cancers and Infectious Diseases
10:16am